Clin2
NCT00044122Likely a fitRecruiting

Study of mast cell growth in people with mastocytosis

MastocytosisMonoclonalBone MarrowTryptase

Part of Cancer, Immune system & allergy clinical trials.

This study looks at what causes mast cells to grow too much in people with mastocytosis. It may help researchers find better ways to diagnose or treat this condition. You can take part in person or by telehealth.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
600 people
Ages
1 day to 80 years
Study type
Observational

Who can take part

  • You have mastocytosis (diagnosed by a skin or bone marrow biopsy, or by a doctor looking at your skin).
  • You are between 0 and 80 years old (if you are under 2, you can do visits by video or phone; if you are 2 or older, you can come to the hospital).
  • You have a regular doctor outside of this study.
  • You do not have severe anemia (very low red blood cell counts).
  • If you are a family member joining, you must be between 2 and 80 and not have mastocytosis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06432556Not yet recruiting
Study of cells in mild mastocytosis patients

This study looks at how different types of cells behave in people with mild forms of mastocytosis (a condition with too many mast cells in the skin). Researchers will take skin samples to understand the disease better, which may help develop future treatments.

Toulouse
NCT06466889Recruiting
Mastocytosis Registry of Zurich

This study is a registry (a simple data collection) for people with mastocytosis or hypertryptasemia who are treated at the University Hospital of Zurich. It aims to gather information to better understand these conditions and improve care.

Zurich
NCT06440148Recruiting
Sclerostin and bone lesions in mastocytosis

This study explores how a protein called sclerostin relates to bone problems in people with mastocytosis. By understanding this link, researchers hope to improve bone health for patients with this rare condition.

Lublin, Lublin Voivodeship
NCT07264959Recruiting
A study on indolent systemic mastocytosis treatments

This study is observing adults with indolent systemic mastocytosis (ISM) who are already receiving or planning to start symptom treatments or the drug avapritinib. It aims to learn more about how these treatments work in real life.

Wheaton, Maryland
NCT05350748Recruiting
MDS study using detailed tests on blood and bone marrow

This study carefully evaluates people with myelodysplastic syndromes (MDS) and closely related blood disorders using detailed medical, blood, and bone marrow testing. The goal is to better understand these conditions and how they progress, which may help guide future care.

Bethesda, Maryland
NCT05588154Recruiting
Donate blood and other samples to study blood cancers

This study asks healthy adults to provide blood, bone marrow (if needed), skin, saliva, and stool samples. Scientists use these samples to compare patterns related to myeloid (bone-marrow) blood cancers, which may help future research and tests.

Bethesda, Maryland

Hear when a new Mastocytosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.